ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.

Mary K McKenna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.